Dillard's Inc. (DDS - Free Report) reported in-line earnings in first-quarter fiscal 2019 while sales lagged estimates. Furthermore, the bottom line declined year over year due to higher markdowns, which significantly impacted margins. Meanwhile, sales were marginally up from the prior-year quarter.
The company’s shares did not react much to the earnings release. However, the stock has gained 5.1% year to date, against the industry’s decline of 12%.
Q1 Numbers
Dillard's reported adjusted earnings per share of $2.77, in line with the Zacks Consensus Estimate. However, earnings declined 4.2% from adjusted earnings of $2.89 in the prior-year quarter.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Dillard's Inc. (DDS - Free Report) reported in-line earnings in first-quarter fiscal 2019 while sales lagged estimates. Furthermore, the bottom line declined year over year due to higher markdowns, which significantly impacted margins. Meanwhile, sales were marginally up from the prior-year quarter.
The company’s shares did not react much to the earnings release. However, the stock has gained 5.1% year to date, against the industry’s decline of 12%.
Q1 Numbers
Dillard's reported adjusted earnings per share of $2.77, in line with the Zacks Consensus Estimate. However, earnings declined 4.2% from adjusted earnings of $2.89 in the prior-year quarter.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ZUMZ - FREE
Get the latest research report on DDS - FREE
Get the latest research report on TLYS - FREE
Get the latest research report on GOOS - FREE